Skip to main content

. 1978 Apr 22;1(6119):1030–1031. doi: 10.1136/bmj.1.6119.1030

Cryptococcosis: survival attributed to combination antifungal treatment.

A M Saunders, A W Goolden, A H Darrell

PMCID: PMC1604015 PMID: 638586

1030

Images in this article

p1030-a
on p.1030

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Diamond R. D., Bennett J. E. Prognostic factors in cryptococcal meningitis. A study in 111 cases. Ann Intern Med. 1974 Feb;80(2):176–181. doi: 10.7326/0003-4819-80-2-176. [DOI] [PubMed] [Google Scholar]
Medoff G., Comfort M., Kobayashi G. S. Synergistic action of amphotericin B and 5-fluorocytosine against yeast-like organisms. Proc Soc Exp Biol Med. 1971 Nov;138(2):571–574. doi: 10.3181/00379727-138-35943. [DOI] [PubMed] [Google Scholar]
Tobias J. S., Wrigley P. F., Shaw E. Combination antifungal therapy for cryptococcal meningitis. Postgrad Med J. 1976 May;52(607):305–308. doi: 10.1136/pgmj.52.607.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
Utz J. P., Garriques I. L., Sande M. A., Warner J. F., Mandell G. L., McGehee R. F., Duma R. J., Shadomy S. Therapy of cryptococcosis with a combination of flucytosine and amphotericin B. J Infect Dis. 1975 Oct;132(4):368–373. doi: 10.1093/infdis/132.4.368. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES